BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11195058)

  • 1. Cyclooxygenase 2 and the kidney.
    Breyer MD; Harris RC
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):89-98. PubMed ID: 11195058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.
    Qi Z; Hao CM; Langenbach RI; Breyer RM; Redha R; Morrow JD; Breyer MD
    J Clin Invest; 2002 Jul; 110(1):61-9. PubMed ID: 12093889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase 1 and 2 in rheumatic disease: implications for nonsteroidal anti-inflammatory drug therapy.
    Spangler RS
    Semin Arthritis Rheum; 1996 Aug; 26(1):435-46. PubMed ID: 8870111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 selective inhibitors and the kidney.
    Breyer MD; Hao C; Qi Z
    Curr Opin Crit Care; 2001 Dec; 7(6):393-400. PubMed ID: 11805541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 and the renal renin-angiotensin system.
    Harris RC; Zhang MZ; Cheng HF
    Acta Physiol Scand; 2004 Aug; 181(4):543-7. PubMed ID: 15283769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of cyclooxygyenase-2-selective inhibitors.
    Brater DC
    J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S15-20; discussion S21-3. PubMed ID: 11992745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective targeting of cyclooxygenase-2 reveals its role in renal medullary interstitial cell survival.
    Hao CM; Kömhoff M; Guan Y; Redha R; Breyer MD
    Am J Physiol; 1999 Sep; 277(3):F352-9. PubMed ID: 10484518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclo-oxygenase isoforms.
    Venturini CM; Isakson P; Needleman P
    Curr Opin Nephrol Hypertens; 1998 Jan; 7(1):79-82. PubMed ID: 9442367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells.
    Guan Y; Chang M; Cho W; Zhang Y; Redha R; Davis L; Chang S; DuBois RN; Hao CM; Breyer M
    Am J Physiol; 1997 Jul; 273(1 Pt 2):F18-26. PubMed ID: 9249588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents].
    Chiolero A; Würzner G; Burnier M
    Nephrologie; 2000; 21(8):425-30. PubMed ID: 11213386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity.
    Khan KN; Venturini CM; Bunch RT; Brassard JA; Koki AT; Morris DL; Trump BF; Maziasz TJ; Alden CL
    Toxicol Pathol; 1998; 26(5):612-20. PubMed ID: 9789947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs.
    Ricketts AP; Lundy KM; Seibel SB
    Am J Vet Res; 1998 Nov; 59(11):1441-6. PubMed ID: 9829404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX2 selective NSAIDs and renal function: gain without pain?
    Breyer MD
    Kidney Int; 1999 Feb; 55(2):738-9. PubMed ID: 9987099
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclooxygenase-2 inhibition and renal physiology.
    Harris RC
    Am J Cardiol; 2002 Mar; 89(6A):10D-17D. PubMed ID: 11909556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of cyclooxygenase-2 selective inhibitors.
    Harris CJ; Brater DC
    Curr Opin Nephrol Hypertens; 2001 Sep; 10(5):603-10. PubMed ID: 11496053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 and the kidney: functional and pathophysiological implications.
    Harris RC
    J Hypertens Suppl; 2002 Sep; 20(6):S3-9. PubMed ID: 12683421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells.
    Hao CM; Yull F; Blackwell T; Kömhoff M; Davis LS; Breyer MD
    J Clin Invest; 2000 Oct; 106(8):973-82. PubMed ID: 11032857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclo-oxygenase isoenzymes: physiological and pharmacological role.
    Kam PC; See AU
    Anaesthesia; 2000 May; 55(5):442-9. PubMed ID: 10792135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between COX-2 and the renin-angiotensin system in the kidney.
    Harris RC
    Acta Physiol Scand; 2003 Apr; 177(4):423-7. PubMed ID: 12648159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cyclooxygenase expression in the kidney by dietary salt intake.
    Yang T; Singh I; Pham H; Sun D; Smart A; Schnermann JB; Briggs JP
    Am J Physiol; 1998 Mar; 274(3):F481-9. PubMed ID: 9530264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.